Processa Pharmaceuticals, Inc. ( PCSA) - Stock Earnings
PCSA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -3.4 million USD | — USD |
| 2025Q4 | -3.4 million USD | — USD |
| 2026Q1 | -3.4 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PCSA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -11.1 million USD | — USD |
| 2024 | -11.9 million USD | — USD |
| 2025 | -13.6 million USD | — USD |
| 2026 Est. | — | — |
PCSA
Price: $2.12
52 week price:
Earnings Per Share: -4.07 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 125600
Market Capitalization: 6.3 million